Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/01/24
End: 03/31/25
Due: 03/31/26
Phase: N/A
Priority: Normal
Start: 01/04/20
End: 02/28/22
Due: 02/28/23
Phase: N/A
Priority: Normal
Start: 03/02/22
End: 01/28/23
Due: 01/28/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Randomized, Double-blind, Placebo-controlled Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JX2105 in Healthy Chinese Subjects | NCT06537050 | Zhejiang Jingxin Pharmaceutical Co., Ltd. | user2@example.com | None | 2024-07-01 | 2025-03-31 | 2026-03-31 | - | - | 2025-07-14 |
| A Safety，Tolerability and Pharmacokinetics Clinical Trial of JX11502MA Capsule | NCT05233657 | Zhejiang Jingxin Pharmaceutical Co., Ltd. | user2@example.com | None | 2020-01-04 | 2022-02-28 | 2023-02-28 | - | - | 2025-07-14 |
| A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia. | NCT06356389 | Zhejiang Jingxin Pharmaceutical Co., Ltd. | user2@example.com | None | 2022-03-02 | 2023-01-28 | 2024-01-28 | - | - | 2025-07-14 |